InvestorsHub Logo
Post# of 252426
Next 10
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

Re: jbog post# 247515

Wednesday, 06/14/2023 7:45:16 PM

Wednesday, June 14, 2023 7:45:16 PM

Post# of 252426

Now that Plax has full approval, they should run a head to head ph2 trial and even if they are just equivalent to plax their the winner.



In what patient population group? How would a phase 2 trial lead to EDP-235 approval?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.